Radiotherapy plus adjuvant goserelin improves survival in men with poor prognosis prostate cancer.
Roach
Mack
M
Department of Radiation Oncology, University of California San Francisco, UCSF Comprehensive Cancer Center, San Francisco, CA, United States.